openPR Logo
Press release

Postpartum Hemorrhage Treatment Devices Market to Reach USD 1.74 Billion by 2035, Growing at 5.7% CAGR

04-30-2025 11:12 PM CET | Health & Medicine

Press release from: FactMR

Postpartum Hemorrhage Treatment Devices Market to Reach USD

​The postpartum hemorrhage treatment devices market size will be USD 998.2 million in 2025. According to Fact.MR analysis, the industry will expand with a CAGR of 5.7% and reach USD 1,740.6 million by the year 2035. The rising incidence of atonic uterus PPH, especially in developing countries, along with growing institutional deliveries, is one of the main drivers of growth.

Advances in technology in minimally invasive care and expanding access to gynecologic care are also fueling the need for efficient management tools for PPH. Postpartum hemorrhage remains a leading cause of maternal mortality, especially in low- and middle-income countries.

Though oxytocin and uterotonic medications have been the mainstay of early intervention for decades, expanding access to device-based interventions such as balloon tamponades, non-pneumatic anti-shock garments (NASG), and intrauterine vacuum-induced devices is radically altering treatment outcomes. They offer rapid, low-cost management of hemorrhage when drugs are not effective or unavailable. More government focus on maternal health, particularly through global health programs, is raising awareness and deployment of treatment for PPH.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=7644

Market Overview

PPH remains a leading cause of maternal mortality, particularly in low- and middle-income countries. Traditional interventions like uterotonic drugs are being supplemented by device-based treatments, including uterine balloon tamponades (UBTs), non-pneumatic anti-shock garments (NASGs), and intrauterine vacuum-induced devices. These devices offer rapid, cost-effective management of hemorrhage, especially when drugs are ineffective or unavailable .​

Key Devices and Innovations

Uterine Balloon Tamponades (UBTs)

UBTs, such as the Bakri balloon, are widely used for controlling PPH. The Bakri balloon, a silicone catheter with a 500 mL capacity, has shown success rates of up to 90% in managing PPH . These devices are endorsed by organizations like the World Health Organization (WHO) and the International Federation of Gynecology and Obstetrics (FIGO).​

Non-Pneumatic Anti-Shock Garments (NASGs)

NASGs are low-technology first-aid devices used to treat hypovolemic shock. They work by returning blood to vital organs, stabilizing women until they can receive definitive care. Studies have shown that NASGs can significantly reduce blood loss, maternal mortality, and the need for emergency hysterectomy .​

Prefilled Injection Systems

Prefilled injection systems, like the Uniject, facilitate the rapid administration of uterotonic drugs. These systems are particularly useful in low-resource settings, ensuring timely intervention to prevent PPH.​

Regional Insights

North America

North America holds a significant share of the PPH treatment devices market, driven by advanced healthcare infrastructure and increased awareness. The U.S. market alone was estimated at USD 278.3 million in 2022 . The FDA's approval of devices like the Jada System, which showed a 94.3% success rate in controlling PPH, further boosts market growth .​

Europe

Europe accounts for 30% of the global market, with countries like Germany, France, and the UK leading in the adoption of advanced maternal care solutions. Over 60% of European healthcare facilities have integrated UBTs and AI-driven hemorrhage monitoring systems into standard obstetric care .​

Asia-Pacific

The Asia-Pacific region is the fastest-growing market, driven by investments in maternal healthcare infrastructure in countries like China, India, Japan, and South Korea. Government and NGO initiatives are promoting affordable treatment solutions to address the high incidence of untreated PPH .​

Challenges and Opportunities

Challenges

High costs of advanced PPH treatment devices pose a significant barrier, especially in developing nations. Over 35% of healthcare facilities in these regions lack access to advanced maternal care solutions. Additionally, regulatory constraints and compliance issues delay the entry of new devices into the market

Opportunities

The integration of AI-based maternal monitoring solutions presents a significant growth opportunity. AI-driven blood loss monitoring systems can detect hemorrhage 30% faster than manual methods. The rise of smart obstetric monitoring tools and wearable health technology contributes to better patient monitoring and early hemorrhage prevention .​

Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=7644

Future Outlook

The PPH treatment devices market is poised for continued growth, driven by technological advancements, increased awareness, and supportive government initiatives. The focus on developing cost-effective, user-friendly devices will be crucial in addressing the challenges faced in low-resource settings. As healthcare systems worldwide prioritize maternal health, the adoption of advanced PPH treatment devices is expected to rise significantly.

Explore More Related Studies Published by Fact.MR Research:

Medical Marker Bands Market

https://www.factmr.com/report/4364/medical-marker-bands-market

Bone Wax Market

https://www.factmr.com/report/bone-wax-market

Gamma Ray-based Robots Market

https://www.factmr.com/report/gamma-ray-based-robots-market

Collagen and HA-based Biomaterials Market

https://www.factmr.com/report/collagen-and-ha-based-biomaterials-market

Breast Surgery Retractors Market

https://www.factmr.com/report/4678/breast-surgery-retractors-market

Manual Resuscitators Market

https://www.factmr.com/report/manual-resuscitators-market

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postpartum Hemorrhage Treatment Devices Market to Reach USD 1.74 Billion by 2035, Growing at 5.7% CAGR here

News-ID: 3995421 • Views:

More Releases from FactMR

Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research Infrastructure
10-08-2025 | Health & Medicine
FactMR
Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research …
The biobanking industry stands at the threshold of a decade-long expansion trajectory that promises to reshape biological sample storage and research infrastructure technology. The market's journey from USD 68.5 billion in 2025 to USD 147.9 billion by 2035 This expansion underscores the industry's pivotal role in modernizing biological sample storage and advancing research infrastructure for pharmaceutical and biotechnology applications. Biobanking's critical contribution to personalized medicine, drug discovery, and disease research positions
Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveiling a Decade of Transformative Growth for Drug Safety and Packaging Innovation
10-08-2025 | Health & Medicine
FactMR
Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveil …
The global Biopharmaceutical Packaging Market is entering a decade of unprecedented expansion, set to nearly double in size from USD 28.5 billion in 2025 to USD 58.2 billion by 2035, registering a robust CAGR of 7.4%. This remarkable growth reflects the rising demand for advanced pharmaceutical packaging systems that enhance sterility, improve drug safety, and streamline regulatory compliance. The market's trajectory is not just about scaling revenue but also about reshaping
3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecast to Reach USD 18.8 billion by 2035
10-08-2025 | Health & Medicine
FactMR
3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecas …
The 3D printing in healthcare industry stands at the threshold of a decade-long expansion trajectory that promises to reshape medical manufacturing and personalized healthcare technology. The market's journey from USD 4.2 billion in 2025 to USD 18.8 billion by 2035This remarkable growth underscores the technology's pivotal role in advancing personalized medicine, surgical precision, and medical device manufacturing, making it an investment priority for forward-looking manufacturers and healthcare technology leaders.Driven by
Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growing at 32.0% CAGR
10-08-2025 | Health & Medicine
FactMR
Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growi …
The global surgical navigation glasses market is expected to reach USD 6,793 Million by 2035, up from estimated value of USD 423.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 32.0%.This exponential trajectory underscores the industry's pivotal role in transforming modern surgical practices, particularly in neurosurgery, orthopedics, and minimally invasive procedures. Fueled by the rapid adoption of Augmented Reality

All 5 Releases


More Releases for PPH

Global Postpartum Hemorrhage (PPH) Devices Market Research Report 2023-2029
Postpartum Hemorrhage (PPH) Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Postpartum Hemorrhage (PPH) Devices market is projected to reach US$ 791.7 million in 2029, increasing from US$ 593.3 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Hospital and Conservation Station are the major drivers for the industry. Global Postpartum Hemorrhage (PPH)
Postpartum Hemorrhage (PPH) Devices Market Sluggish Growth Rate Projected 2023-2 …
Postpartum Hemorrhage (PPH) Devices Market is expected to witness moderate growth registering 6.2% CAGR during the forecast period (2023-2029). By observing alternative approaches, this Postpartum Hemorrhage (PPH) Devices Market research report aims to analyze the sales force for product distribution. It helps key players reduce investment risk by providing relevant data and business considerations. Key organizations can easily get a clear view of current market conditions and ideas to make their
07-01-2020 | Sports
iBet
PayPerHead.net launches PPH review site
New Industry reviewing portal will encompass all PPH companies and assess the benefits of each PPH software service. 29.06.2020 – San Jose, Costa Rica PayPerHead.net – the advanced pay per head bookie service supporting industry growth at all levels – has announced its launch of a review site which will compare the features and benefits of all pay per head (PPH) providers on the market. The new review platform will seek to break
Polypropylene Homopolymer (PPH) Resin Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Polypropylene Homopolymer (PPH) Resin market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Polypropylene Homopolymer (PPH) Resin market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Polypropylene Homopolymer (PPH) Resin market,
PPH Devices Market : The Next Big Thing in Medical Device Industry
Post-partum Hemorrhage (PPH) Devices Market Report, published by Allied Market Research, was valued at $637 million in 2015, and is expected to garner $906 million by 2022, registering a CAGR of 5.2% during the period 2016 - 2022.The Uterine balloon tamponade is expected to remain the highest revenue-generating segment throughout the forecast period. Download Request Sample Copy: https://www.alliedmarketresearch.com/request-sample/1676 The factors that are expected to drive the growth of the PPH market are:
Global Postpartum Hemorrhage (PPH) Treatment Devices Market is Primarily being D …
The global postpartum hemorrhage treatment devices market is progressing at a CAGR of 4.9% within a forecast period of 2015 to 2023. Owing to this positive growth rate, the market is expected to reach US$926.1 mn before the end of 2023. The global postpartum hemorrhage treatment devices market was recorded at US$604.4 mn in 2014, according to a research report released by Transparency Market Research. The report, titled “Postpartum Hemorrhage